Ambu A/S
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Ambu A/S - overview
Established
1937
Location
-, -, Denmark
Primary Industry
Medical Devices & Equipment
About
Ambu A/S is a Denmark-based company that specializes in innovative single-use medical devices for various healthcare applications, focusing on improving patient care and safety in medical procedures. Founded in 1937 in Denmark, Ambu A/S develops single-use medical devices. The company has not undergone any significant pivots in its operational strategy. Ambu operates globally with offices in Europe, North America, and Asia.
Ambu A/S is a leading provider of single-use medical devices, specializing in innovative solutions for various healthcare applications, including endoscopy, patient monitoring, and emergency care. Their core product offerings encompass single-use endoscopes, such as the Ambu® aScope™ series, designed for procedures in pulmonology, gastroenterology, and ENT practices, among others. These devices feature advanced imaging capabilities and exceptional maneuverability, aiming to minimize contamination risks during medical procedures. Ambu also offers a range of products tailored for cardiology, neurology, and airway management, addressing critical needs in hospital settings and emergency care environments.
The company serves a diverse global client base, including hospitals, clinics, and medical professionals across various geographical markets, including North America, Europe, Asia, and Australia. In the most recent fiscal year of 2023, Ambu A/S generated revenue of USD 684. 75 mn, with an EBITDA of USD 88. 91 mn.
The company's revenue primarily comes from the sale of single-use medical devices directly to healthcare institutions and intermediaries, supported by ongoing partnerships with distributors and a focus on subscription models for select product lines. Ambu A/S is strategically focusing on expanding its product offerings with plans to launch new single-use endoscopes designed for enhanced functionality by mid-2024. The company also aims to penetrate new markets, particularly in Asia and South America, by the end of 2025. Recent funding will be allocated to further research and development, ensuring the introduction of innovative products that meet the evolving needs of healthcare providers.
Primary Industry
Medical Devices & Equipment
Sub Industries
Healthcare, Healthcare IT, Medical Devices & Equipment
Website
www.ambu.com
Verticals
HealthTech, Wearables & Quantified Self
Total Amount Raised
Subscriber access only
Ambu A/S - financials
| Fiscal Year Ended | Sep 30, 2011 | Sep 30, 2012 | Sep 30, 2013 | Sep 30, 2014 | Sep 30, 2015 | Sep 30, 2016 | Sep 30, 2017 | Sep 30, 2018 | Sep 30, 2019 | Sep 30, 2020 | Sep 30, 2021 | Sep 30, 2022 | Sep 30, 2023 | Sep 30, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 982,812,000 | 1,045,457,000 | 1,383,000,000 | - | 1,889,000,000 | 2,084,000,000 | 2,355,000,000 | 2,606,000,000 | 2,820,000,000 | 3,567,000,000 | 4,013,000,000 | - | - | - |
| % Revenue Growth (YoY) | - | 6.4% | 32.3% | - | - | 10.3% | 13.0% | 10.7% | 8.2% | 26.5% | 12.5% | - | - | - |
| EBITDA (USD) | 167,679,000 | 204,243,000 | 174,000,000 | - | 332,000,000 | 456,000,000 | 554,000,000 | 677,000,000 | 411,000,000 | 599,000,000 | 552,000,000 | - | - | - |
| Operating Income (USD) | 111,334,000 | 150,667,000 | 100,000,000 | - | 236,000,000 | 356,000,000 | 450,000,000 | 563,000,000 | 306,000,000 | 428,000,000 | 340,000,000 | - | - | - |
| Operating Margin | 11.3% | 14.4% | 7.2% | - | 12.5% | 17.1% | 19.1% | 21.6% | 10.9% | 12.0% | 8.5% | - | - | - |
| % EBITDA Margin | 17.1% | 19.5% | 12.6% | - | 17.6% | 21.9% | 23.5% | 26.0% | 14.6% | 16.8% | 13.8% | - | - | - |
| NET Income (USD) | 69,213,000 | 114,713,000 | 48,000,000 | - | 152,000,000 | 250,000,000 | 301,000,000 | 337,000,000 | 317,000,000 | 241,000,000 | 247,000,000 | - | - | - |
| % Net Margin | 7.0% | 11.0% | 3.5% | - | 8.0% | 12.0% | 12.8% | 12.9% | 11.2% | 6.8% | 6.2% | - | - | - |
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.